United States · FDA National Drug Code directory

Loperamide Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
55289-315_4199e187-f646-693a-e063-6294a90ae583
Product NDC
55289-315
Form
CAPSULE
Composition / generic term
Loperamide Hydrochloride
Labeler
PD-Rx Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
19930501
Source listing expiry
20261231

Source-listed ingredients

  • LOPERAMIDE HYDROCHLORIDE — 2 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 6 CAPSULE in 1 BOTTLE, PLASTIC (55289-315-06) · 55289-315-06
  • 8 CAPSULE in 1 BOTTLE, PLASTIC (55289-315-08) · 55289-315-08
  • 10 CAPSULE in 1 BOTTLE, PLASTIC (55289-315-10) · 55289-315-10
  • 12 CAPSULE in 1 BOTTLE, PLASTIC (55289-315-12) · 55289-315-12
  • 15 CAPSULE in 1 BOTTLE, PLASTIC (55289-315-15) · 55289-315-15
  • 20 CAPSULE in 1 BOTTLE, PLASTIC (55289-315-20) · 55289-315-20
  • 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-315-30) · 55289-315-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →